Summit Therapeutics (SMMT) Q3 2025 Earnings

Aug 11Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.76
-0.52
-0.29
-0.05

Details

Expected EPS
-0.090813
Actual EPS
-0.76
Surprise EPS
-0.67
Surprise Percent
-736.88%

Description

⁨Summit Therapeutics⁩ (⁦SMMT⁩) has reported earnings of ⁦-0.76⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts